BioSpace News Archive

Press Releases

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference

October 21, 2025
·
2 min read
Press Releases

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

October 21, 2025
·
6 min read
Press Releases

Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer

October 21, 2025
·
5 min read
Press Releases

RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria

October 21, 2025
·
9 min read
Press Releases

The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients

October 21, 2025
·
4 min read
Press Releases

RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor

October 21, 2025
·
30 min read
Press Releases

The results of the EMPRESS study show the activity of giredestrant in reducing tumor proliferation in ER+/HER2- breast cancer at early stages without the need for ovarian function suppression

October 21, 2025
·
4 min read
Press Releases

Innoviva Specialty Therapeutics Announces Oral Presentation Featuring New Analyses from the Zoliflodacin Pivotal Phase 3 Trial at IDWeek 2025

October 21, 2025
·
8 min read
Press Releases

Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer

October 21, 2025
·
5 min read
Press Releases

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

October 21, 2025
·
3 min read